National Drug and Alcohol Research Centre - Other Publications

Print Friendly Print this page

National Drug and Alcohol Research Centre


IDRS and EDRS Publications


The following publications have arisen from the results of the IDRS and EDRS:
The National Illicit Drug Indicators Project (NIDIP) web page also contains a list of publications.


Peer-reviewed Publications


2010

Dunn, M., Day C., Bruno, R., Degenhardt, L. & Campbell, G. (2010). Sexual and injecting risk behaviours among regular ecstasy users. Addictive Behaviours, 35, 157-160.

2009

George, J., Kinner, S., Bruno, R., Degenhardt, L. & Dunn, M. (in press). Contextualising psychological distress among regular ecstasy users: The importance of sociodemographic factors and patterns of drug use. Drug and Alcohol Review.

Miller, P., Johnston, J., Dunn, M., Fry, C., & Degenhardt, L. (in press). Comparing probability and non-probability sampling methods in ecstasy research: Implications for the Internet as a research tool. Substance Use & Misuse.

Bruno, R., Matthews, A.J., Topp, L., Degenhardt, L., Gomez, R. & Dunn, M. (2009). Can the Severity of Dependence Scale be usefully applied for ‘ecstasy’? Neuropsychobiology, 60, 3-4, 137-147..

Kinner, S. A., George, J., Campbell, G., & Degenhardt, L. (2009). Crime, drugs and distress: Patterns of drug use and harm among criminally involved injecting drug users in Australia. Australian and New Zealand Journal of Public Health, 33 (3) 223-227.

Degenhardt, L., Roxburgh, A., Dunn, M., Campbell, G, Bruno, R., Kinner, S.A., George, J., Quinn, B., White, N. & Topp, L. (2009). The epidemiology of ecstasy use and harms in New South Wales, Australia. Neuropsychobiology, 60, 3-4, 176-187..

Dunn, M., Topp, L. & Degenhardt, L. (2009). GHB in New South Wales, Australia, 2000-2006: a case study of the EDRS as a strategic early warning system. International Journal of Drug Policy, 20, 413-417.

Dunn, M. & Degenhardt, L. (2009). The use of drug detection dogs in Sydney, Australia. Drug and Alcohol Review , 28, 658-662..

Matthews, A., Bruno, R., Johnston, J., Black, E., Degenhardt, L. & Dunn, M. (2009). Risk factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users. Drug and Alcohol Dependence, 100, 1, 24-31

2008

Degenhardt, L., Kinner, S. A., Roxburgh, A., Black, E., Bruno, R., Fetherston, J., et al. (2008). Drug use and risk among regular injecting drug users in Australia: does age make a difference? Drug and Alcohol Review, 27(4), 357-360.

Degenhardt, L., Roxburgh, A., Black, E., Campbell, G., Bruno, R., & Kinner, S. (2008). The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review, 27(3), 243-252.

Degenhardt, L., Roxburgh, A., Van Beek, I, Hall, W.D., Robinson, M.K.F., Ross J., Mant, A. (2008). The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia. Drug and Alcohol Review, 27(2), 145-151.

Kinner, S., Degenhardt, L. (2008). The emergence of crystal methamphetamine smoking in Australia. Drug and Alcohol Review, 27(30), 292-300.

2007

(None)

2006

Black, E. & Degenhardt, L. (2006). Drug-related aggression among injecting drug users. NSW Public Health Bulletin 17, 12.

Breen, C., Degenhardt, L., Kinner, S., Bruno, R., Jenkinson, R., Matthews, A., & Newman, J. (2006). Alcohol use and risk taking among regular ecstasy users. Substance Use and Misuse 41, 1095-1109.

Day, C., Degenhardt, L. & Hall, W. (2006). Changes in the initiation of heroin use after a reduction in heroin supply. Drug and Alcohol Review 25, 307-313.

Degenhardt, L., Black, E., Breen, C., Bruno, R., Kinner, S., Roxburgh, A., Fry, C., Jenkinson, R., Ward, J., Fetherston, J., Weekley, J., & Fischer, J. (2006). Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug and Alcohol Review, 25, 403-412.

Johnston, J., Barratt, M.J., Fry, C.L., Kinner, S., Stoové, M., Degenhardt, L., George, J., Jenkinson, R., Dunn, M. & Bruno, R. (2006). A survey of regular ecstasy users’ knowledge and practices around determining pill content and purity: Implications for policy and practice. International Journal of Drug Policy 17, 464-472.

Kinner, S. & Degenhardt, L. (2006). Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia. Drug and Alcohol Review 25, 445-449.

White, B., Degenhardt, L., Breen, C., Bruno, R., Newman, J., & Proudfoot, P. (2006). Risks and benefits perceptions of party drug use. Addictive Behaviors 31, 137-142.

White, B., Day, C., Degenhardt, L., Kinner, S., Fry, C., Bruno, R., & Johnston, J. (2006). Prevalence of injecting drug use and associated risk behaviour among regular injecting ecstasy users in Australia. Drug and Alcohol Dependence 83, 210-217.

2005

Breen, C., Roxburgh, A. & Degenhardt, L. (2005). Gender differences among regular injecting drug users in Sydney, Australia, 1996-2003. Drug and Alcohol Review 24, 353-358.

Degenhardt, L., Conroy, E., Gilmour, S., & Collins, L. (2005). The effect of a reduction in heroin supply in Australia upon drug distribution and acquisitive crime. British Journal of Criminology 45, 2-24.

Degenhardt, L., Day, C., Dietze, P., Pointer, S., Conroy, E., Collins, L., & Hall, W. (2005). Effects of a sustained heroin shortage in three Australian States. Addiction 100, 908-920.

Degenhardt, L., Day, C., Hall, W., Conroy, E., & Gilmour, S. (2005). Was an increase in cocaine use in New South Wales, Australia, accompanied by an increase in violent crime? BMC Public Health, 5.

Degenhardt, L., Reuter, P., Collins, L., & Hall, W. (2005). Evaluating explanations of the Australian "heroin shortage". Addiction 100, 459-469.

Jenkinson, R., Clark, N., Fry, C., & Dobbin, M. (2005). Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 100, 197-205.

2004

Breen, C., Degenhardt, L., Bruno, R., Roxburgh, A., & Jenkinson, R. (2004). The impact of the restriction of publicly subsidised 10mg temazepam capsules upon benzodiazepine use among injecting drug users in Australia. Medical Journal of Australia 181, 300-305.

Longo, M., Henry-Edwards, S., Humeniuk, R., Christie, P., & Ali, R. (2004). Impact of the heroin "drought" on patterns of drug use and drug-related harms. Drug and Alcohol Review 23, 143-150.

Roxburgh, A., Degenhardt, L. & Breen, C. (2004). Changes in patterns of drug use among injecting drug users following a reduction in the availability of heroin in New South Wales, Australia. Drug and Alcohol Review 23, 287-294.

Topp, L., Barker, B. & Degenhardt, L. (2004). The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence 73, 33-40.

Topp, L., Breen, C., Kaye, S., & Darke, S. (2004). Adapting the Illicit Drug Reporting System (IDRS) methodology to examine the feasibility of monitoring trends in party drug markets. Drug and Alcohol Dependence 73, 189-197.

2003

Day, C., Topp, L., Rouen, D., Darke, S., Hall, W., & Dolan, K. (2003). Decreased heroin availability in Sydney Australia in early 2001. Addiction 98, 93-95.

Degenhardt, L., Topp, L. & Day, C. (2003). Issues surrounding the detection of a reduction in drug supply: The case of the heroin shortage in Australia, 2001. WHO Bulletin on Narcotics LIV, 131-140.

Shand, F., Topp, L., Darke, S., Makkai, T., & Griffiths, P. (2003). The monitoring of drug trends in Australia. Drug and Alcohol Review 22, 63-74.

Topp, L., Day, C. & Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence 70, 275-286.

Topp, L., Degenhardt, L., Day, C., & Collins, L. (2003). Contemplating drug monitoring systems in the light of Australia's 'heroin shortage'. Invited Editorial. Drug and Alcohol Review 22, 3-6.

Topp, L. & Mcketin, R. (2003). Supporting evidence-based policy-making: A case study of the Illicit Drug Reporting System. United Nations Bulletin on Narcotics, LIV.

2002

Darke, S., Kaye, S. & Topp, L. (2002). Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Drug and Alcohol Dependence 67, 73-79.

Darke, S., Topp, L., Kaye, S., & Hall, W. (2002). Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction 97, 179-186.

Darke, S., Topp, L. & Ross, J. (2002). The injection of methadone and benzodiazepines among Sydney IDU 1996-2000: 5 year monitoring of trends from the Illicit Drug Reporting System (IDRS). Drug and Alcohol Review 21, 27-32.

Fry, C. & Bruno, R. (2002). Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania. Drug and Alcohol Review 21, 363-367.

Topp, L., Degenhardt, L., Kaye, S., & Darke, S. (2002). The emergence of potent forms of methamphetamine in Sydney, Australia; A case study of the IDRS as a strategic early warning system. Drug and Alcohol Review 21, 341-348.

2000

McKetin, R. (2000). The Illicit Drugs Reporting System. NSW Public Health Bulletin 11, 49-52.

1998

Hando, J., Darke, S., O'Brien, S., Maher, L., & Hall, W. (1998). The development of an early warning system to detect trends in illicit drug use in Australia: the Illicit Drug Reporting System. Addiction Research 6, 97-113.


Historical Publications



Development of the IDRS


Technical Report 292 is a reprinted version of an original report submitted by Dr Grant Wardlaw to the Australian Government Department of Health Ageing. The report reviews methods for monitoring illicit drug trends, and presents important contextual information on the historical origins of the IDRS and its sister project - the EDRS (Ecstasy and Related Drug Reporting System). (full text pdf version)

Further information about the development and achievements of the IDRS, is provided in a paper written by Dr Libby Topp – ‘A timely, effective and cost effective way to support evidence-based policy making’.

Development of the EDRS


Further information on the development of the EDRS, including the feasiblity of adapting the IDRS methodology to monitor ecstasy and related drugs, is provided in Technical Reports 142 (full text pdf version) and 236 (full text pdf version).

Press Releases


The following IDRS and EDRS press releases are available in PDF format:




IDRS

Further Information


Natasha Sindicich
T +61 (2) 9385 0191
F +61 (2) 9385 0222
E n.sindicich@unsw.edu.au

Jennifer Stafford
T +61 (2) 9385 0244
F +61 (2) 9385 0222
E j.stafford@unsw.edu.au



National Drug and Alcohol Research Centre - UNSW Faculty of Medicine NSW 2052 Australia | Tel: +61 (2) 9385 0333 Fax:+61 (2) 9385 0222
© Copyright 2005 UNSW Faculty of Medicine | CRICOS Provider Code: 00098G | Authorised by Centre Director
Page Last Updated: Monday, 16 November 2009